A 68-year-old man has new breathlessness and orthopnoea. His ejection fraction is 30 percent. Which combination forms the core of long-term drug treatment for heart failure with reduced ejection fraction?

Answer and explanation

Correct answer: B. An ACE inhibitor, a beta-blocker, a mineralocorticoid receptor antagonist and an SGLT2 inhibitor

  1. Step 1: Heart failure with reduced ejection fraction has a prognostic drug set.
  2. Step 2: NICE and ESC-style guidance use an ACE inhibitor or ARNI, beta-blocker, MRA and SGLT2 inhibitor, with diuretics for congestion.
Answer
An ACE inhibitor, a beta-blocker, a mineralocorticoid receptor antagonist and an SGLT2 inhibitor.
Why not the others: A loop diuretic alone, continued indefinitely at the lowest dose to control his symptoms and fluid: Diuretics relieve congestion but do not improve survival. An NSAID and a thiazide diuretic taken on alternate days to relieve joint pain and swelling: NSAIDs worsen heart failure. A calcium channel blocker, digoxin and regular long-term aspirin for symptom and rate control: CCBs such as verapamil are harmful in HFrEF and aspirin is not part of therapy.

Practise more Cardiorespiratory medicine.

Free questions with an explanation for every one, and full timed PLAB 1 (GMC, international medical graduates) mock tests.